Global Immunoglobulin Market Report and Forecast 2024-2032

Global Immunoglobulin Market Outlook

The global immunoglobulin market attained a value of about USD 14.62 billion in 2023. The market is further expected to grow in the forecast period of 2024-2032 at a CAGR of 7.1% to reach approximately USD 27.17 billion by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Rising Applications of Immunoglobulin in Hypogammaglobulinemia to Boost the Global Market

North America is considered the dominant regional market for immunoglobulin, owing to the rapid development of antibody therapy in the healthcare sector within the region. During the onset of the coronavirus pandemic, the region witnessed a massive increase in clinical trials of immunoglobulins across various phases of development, which aided the market as a prominent driving factor. The active and dynamic market for pharmaceuticals in the region facilitates multiple beneficial mergers and acquisitions, which subsequently fuels this trend of growth. By the route of administration, the market share held by the intravenous segment is multiple folds larger than that hold by the subcutaneous segment, mainly due to the high availability of products and rapid absorption rate in the intravenous form. Moreover, immunoglobulin finds its application across various conditions, among which hypogammaglobulinemia is estimated to continue its dominance in the global market owing to the significant increase in the prevalence of the associated disorder over the years.

Immunoglobulin: Market Segmentation

An immunoglobulin, also termed an antibody, is a protein biologically produced by plasma cells and other lymphocytes, which is used by the immune system to detect and destroy disease-causing pathogens. Commercial immunoglobulin is a blood product obtained through the process of fractionation and purification for therapeutic and research applications.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The major applications of immunoglobulin are:

• Hypogammaglobulinemia
• CIPD
• Immunodeficiency Diseases
• Congenital AIDS
• Chronic Lymphocytic Leukaemia
• Myasthenia Gravis
• Multifocal Motor Neuropathy
• ITP
• Kawasaki Disease
• Guillain-Barre Syndrome

Based on route of administration, the industry is segmented into:

• Intravenous
• Subcutaneous

The market can be broadly categorised on the basis of clinical trial into:

• IgG
• IgA
• IgM
• IgE
• IgD

The EMR report looks into the regional markets of immunoglobulin like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Prevalence of Immunodeficient and Neurological Diseases to Provide Lucrative Opportunities for Immunoglobulin Industry Growth

The global market for immunoglobulin is mainly propelled by the rise in prevalence of immunodeficiency diseases and the emergence of enhanced purification techniques which offer a better yield of plasma. Furthermore, spatial genomic analysis, aided by immunoglobulins, yields a biomarker for cancer diagnostics, whose rising demand is expected to boost the market growth for immunoglobulins. The products also find use in the treatment of neurological disorders, which acts as an additional driving force for the demand growth. Moreover, improvements in the research and development sector for the creation of new products for the control of diseases is expected to drive market growth. Meanwhile, the existence of certain side effects associated with the use of immunoglobulins, and the resultant stringent government policies, are some of the few factors which can be considered as obstacles. However, with time, scientific advancements are likely to counter them and pave the way for robust market growth.

Key Industry Players in the Global Immunoglobulin Market

The report presents a detailed analysis of the following key players in the global immunoglobulin market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

• Biotest AG
• Octapharma AG
• Baxter International Inc.
• China Biologics Products Inc.
• Grifols SA

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

Key Highlights of the Report

Immunoglobulin Market Report Snapshots

Immunoglobulin Market Size

Immunoglobulin Companies